Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


四月 26, 2019

Overcoming Challenges Associated with Biologic Drug Formulation and Development

Standing front and foremost in biologic drug formulation is the optimization of safety and efficacy while ensuring quality and stability during manufacturing. Biologic manufacturing subjects the formulation to different stresses and conditions that may compromise quality and stability. Recently, the requirement for the development of subcutaneous formulations for high dose drugs, such as monoclonal antibodies, at high protein concentrations has created additional challenges, including degradation.
Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

四月 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

Introducing Integrated Solutions

十月 08, 2018

Introducing Integrated Solutions

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

The SmartDose Platform in use

八月 10, 2018

Combination Products - Why Design Verification Studies Are Needed

Daniel Bantz

Daniel Bantz

Technical Manager, Packaging & Performance, Lab

SmartDose Platform

八月 08, 2018

Performance Testing: Strategies to Qualify Combination Products

Page McAndrew

T. Page McAndrew, Ph.D.

Director, Scientific Communications, SA & TS

Mixject Admixture System

一月 30, 2018

Co-Packaged Combination Products – System vs Component

Doug Hostetler

Doug Hostetler

Principle SME, Admin. Systems, TCS